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Background: Myocardial function in very-low-birth-weight infants (VLBWIs) develops
during early postnatal life, but different patterns of temporal evolution that might
be related to the development of bronchopulmonary dysplasia (BPD) are not
completely understood.
Methods: A prospective cohort study including VLBWIs admitted to our NICU from
January 2015 to 2017 was conducted. Plasma N-terminal pro B type natriuretic peptide
(NTproBNP) levels were measured, and echocardiograms were performed at 24 and 72 h
of life and weekly thereafter until 36 weeks of postmenstrual age (PMA). We measured
the tricuspid annular plane systolic excursion (TAPSE) by M-mode; the lateral tricuspid E’,
A’, and S’ waves; and the myocardial performance index (MPI) by tissue doppler imaging
(TDI). The subjects were divided into non-BPD and BPD groups.
Results: We included 101 VLBWIs. The TAPSE and E’, A’, and S’ waves increased while
MPI-TDI decreased over time. Birth gestational age (GA) and postnatal PMA impacted
these parameters, which evolved differently in those who developed BPD compared
to those in the non-BPD group. The NTproBNP levels at 14 days of life and different
echocardiographic parameters were associated with the development of BPD in different
multivariate models.
Conclusion: TAPSE and TDI values depend on GA and PMA and follow a different
temporal evolution that is related to the later development of BPD. Combined biochemical
and echocardiographic biomarkers can help identify which VLBWIs are at higher risk of
developing BDP.
Keywords: bronchopulmonary dysplasia, preterm infants, myocardial function, N-terminal pro B type natriuretic
peptide, tissue doppler imaging, targeted neonatal echocardiography, biomarkers, tricuspid annular plane systolic
excursion
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INTRODUCTION
Bronchopulmonary dysplasia (BPD) is a severe complication
of prematurity that impacts the survival and development of
very-low-birth-weight infants (VLBWIs) (1). The incidence of
BPD in VLBWIs remains stable at ∼25% despite improvements
in neonatal care and the survival rate of this population (1).
VLBWIs with BPD have increased lengths of hospital stay and
greater morbidity and mortality (2). There is an increasing body
of research aiming to identify early markers associated with
BPD development in VLBWIs that could help identify high-risk
infants who would benefit from potential preventive strategies
(3, 4).
Targeted neonatal echocardiography (TnEcho) has expanded
in neonatal intensive care units as an additional tool in the
hemodynamic assessment of newborns (5). Recently, there
has been growing research interest in the potential role of
conventional and emerging echocardiographic modalities, such
as tissue Doppler imaging (TDI), in the assessment of newborn
and VLBWIs cardiopulmonary morbidities including patent
ductus arteriosus (PDA) and BPD (6). Normative values of
TnEcho parameters have been described for children (7) and
healthy newborns (8). Nevertheless, myocardial function in the
VLBWIs is known to be different from that of the term newborn
(9), but the influence of postnatal life on VLBWIs myocardial
maturation and how it differs in those who later develop BPD
are not completely understood (10).
However, biochemical biomarkers, such as N-terminal pro B
type natriuretic peptide (NTproBNP), have been associated with
neonatal morbidities, such as persistent pulmonary hypertension
(11) and PDA (12). In infants with BPD, NTproBNP is a
suggestedmarker of pulmonary hypertension (3, 13). NTproBNP
levels in the first month of life increase in VLBWIs who develop
BPD (12, 14), as we have previously shown (15), and are related
to the degree of BPD (16, 17).
This study aims to evaluate the temporal evolution of
VLBWI myocardial function related to gestational age (GA)
and postmenstrual age (PMA) and to explore the potential role
of right ventricle (RV) TDI-derived measurements, tricuspid
annular plane systolic excursion (TAPSE) and NTproBNP
together to detect early signs of myocardial dysmaturation in
infants who develop BPD.
MATERIALS AND METHODS
Subjects
This was a prospective observational study that included
VLBWIs admitted to the Neonatal Intensive Care Unit of
the University Hospital Puerta del Mar (Cadiz, Spain) from
January 2015 to 2017. The institutional research ethics committee
Abbreviations: BPD, Bronchopulmonary dysplasia; VLBWIs, very-low-birth-
weight infants; TnEcho, Targeted neonatal echocardiography; TDI, tissue Doppler
imaging; PDA, patent ductus arteriosus; NTproBNP, N-terminal pro B type
natriuretic peptide; GA, gestational age; PMA, postmenstrual age; RV, right
ventricle; TAPSE, tricuspid annular plane systolic excursion; E’, Early diastolic
velocity; A’, late diastolic velocity; S’, systolic velocity; MPI-TDI, The myocardial
performance index measured by TDI; DOL, days of life.
approved the study, and written informed consent was obtained
from the parents in accordance with the Declaration of Helsinki.
Patients with birth weights ≤1,500 g and/or a GA of ≤32 weeks
were included. Exclusion criteria were congenital heart disease
(except patent foramen ovale or atrial septal defect, ventricular
septal defect < 2mm, or PDA); genetic syndrome or major
congenital malformations; death in the first week of life; and a
lack of informed consent from the parents.
We defined a subgroup of VLBWIs that we considered
“healthy VLBWIs” to define the normal values of the different
echocardiographic parameters. We considered “healthy
VLBWIs” those with an adequate weight for GA (18–20), with
no hemodynamically significant PDA (21, 22) (defined as PDA
<1.5mm in any TnEcho or < 1mm after 32 weeks PMA) and
no BPD (23). The myocardial maturation of preterm infants
who are born small for gestational age has been suggested to be
affected from intrauterine life and this could be reflected in a
worse cardiac function detected from birth to childhood (24).
Preterm infants who develop BPD may have an increased RV
afterload secondary to an incipient vascular lung disease, on the
other hand, a PDA would increase the left ventricle preload, and
could also worsen myocardial function (18).
Measurements
The following variables were collected: GA, birth weight,
sex, small for gestational age (SGA), premature rupture of
membranes, chorioamnionitis, 5min Apgar score, clinical risk
index for babies (CRIB), prenatal steroid use, hyaline membrane
disease, sepsis, postnatal steroids, need of inhaled nitric oxide
(iNO), severe intraventricular hemorrhage with or without
parenchymal infarction, white matter injury, PDA, retinopathy
of prematurity, and necrotizing enterocolitis. The need for and
duration of mechanical ventilation were also recorded. The
included VLBWIs were classified into two groups according to
the presence or absence of BPD defined as the need for oxygen
or respiratory support at 36 weeks of PMA (25). BPD was
further classified in moderate or severe BPD: moderate BPD was
considered if <30% oxygen was needed and severe BPD if more
than 30% oxygen was needed or the infants was on respiratory
support (25).
TDI was performed at the lateral ring of the tricuspid valves
from an apical four chamber view using a sample volume size
of 1.5mm and maintaining an angle of insonation of <20◦
with respect to the orientation of the ventricular wall. No angle
correction was made, and gains were minimized to allow a clear
signal from the tissue (26). Early diastolic (E′), late diastolic
(A′), and systolic (S′) velocities were measured. The myocardial
performance index measured by TDI (MPI-TDI) was calculated
as (a–b)/b, where “a” is the time interval from the end of wave A′
to the beginning of wave E′ and “b” is the interval between the
beginning and end of the S′ wave. TAPSE was measured by M-
mode echocardiography with the scan line passing through the
lateral face of the tricuspid ring, maintaining vertical alignment
with the apex (5) (Figure 1).
To measure NTproBNP plasma levels, 0.5ml of blood
sample was collected in ethylenediaminetetraacetic acid (EDTA),
transported at room temperature and processed immediately
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FIGURE 1 | Measurement of the tricuspid annular plane systolic
excursion (TAPSE).
for analysis. NTproBNP levels were calculated by means of the
electroluminescence immunoassay kit (ECLIA) with the Elecsys
proBNP II test (Roche Diagnostics).
Protocol
Echocardiograms were performed in the first 24 and 72 h of
life and then weekly until 36 weeks of PMA. The exam was
performed with extreme care and minimization of the study
time. The echocardiographic evaluation was not performed
if the VLBWI was unstable, and the procedure was stopped
if the patient’s condition deteriorated. Two neonatologists
with specific training in neonatal echocardiography performed
the studies using a Philips iE33 with an 8–3Hz transducer
according to the recommendations of the American Society
of Echocardiography (5). The interobserver and intraobserver
reproducibility was previously analyzed and reported by
our group (27). Electrocardiographic records were taken
simultaneously. The studies were digitally stored and analyzed
oﬄine. At least three consecutive beats were recorded in sinus
rhythm, and the mean values were recorded.
Following the same schedule as the echocardiographic exam,
but only if a blood test was clinically indicated, NTproBNP levels
were measured.
Data Analysis
The quantitative variables are described as the mean and
standard deviation (SD) or median and range according to
their distributions. Qualitative variables are expressed as the
frequency and percentage. The bivariate analysis was performed
with parametric or non-parametric techniques after testing
for normality.
As a first approach, we studied the temporal evolution of
the TAPSE, E’, A, and S’ velocities of the RV in the “healthy
VLBWI” subgroup, related to GA and PMA. GA was divided
into three groups: 25–27+6, 28–30+6, and 31–32+6 weeks. The
TABLE 1 | Perinatal variables in no-BPD and BPD groups.
Non-BPD
(n = 86)
BPD
(n = 15)
Total
(n = 101)
p
GA 29.13 ± 1.79 27.27 ± 1.3 29 (25–32) 0.0002*
Weight (g) 1,200
(600–1,680)
850
(580–1,400)
1,150
(580–1,680)
0.0001*
Sex, male 45 (52.33%) 11 (72.3%) 56 (55.45 %) 0.13
SGA 9 (10.47%) 4 (26.67%) 13 (12.87%) 0.084
Apgar 5 8 (4–10) 7 (4–8) 7 (4–10) 0.002*
CRIB 1 (0–7) 5 (1–12) 1 (0–12) 0.0001*
Chorioamnionitis 12 (13.95%) 4 (26.67%) 16 (15.84%) 0.2
Prenatal steroids
(≥1 dose)
72 (83.72%) 14(93.33%) 86 (85.15%) 0.33
Cesarean
section
72 (83.72%) 12 (80%) 84 (83.17%) 0.72
Early onset
sepsis
1 (1.16%) 0 1 (0.99%) 0.67
Late onset
sepsis
12 (13.95%) 5 (33.33%) 17 (16.83%) 0.064
Hyaline
membrane
disease
51 (59.3%) 13 (86.67%) 64 (63.37%) 0.04
Mechanical
ventilation
53 (61.63%) 14 (93.33%) 67 (67.6%) 0.016*
Days of
mechanical
ventilation
3 (0–39) 40 (0–173) 14.16 ± 29.87 0.0001*
Postnatal
steroids
1 (1.16%) 3 (20%) 4 (3.96%) 0.001
iNO 4 (4.65%) 2 (13.33%) 6 (5.94) 0.189
PDA 37 (43.02%) 12 (80%) 49 (48.5%) 0.011*
Severe IVH 2 (2.33%) 1 (6.67%) 3 (2.97%) 0.39
White matter
injury
2 (2.33%) 1 (6.67%) 3 (2.97%) 0.39
Severe ROP 7(8.14) 5 (33.33) 12 (%) 0.016*
NEC 3 (3.49%) 0 3 (3.49%) 1.00
GA, Gestational age (weeks); BPD, bronchopulmonary dysplasia; SGA, small for
gestational age; iNO, inhaled nitric oxide; PDA, patent ductus arteriosus; Severe IVH,
Grade III intraventricular hemorrhage or parenchymal hemorrhagic infarction; Severe
ROP, retinopathy of prematurity ≥ grade 2; NEC, Necrotizing enterocolitis; p, Statistical
significance (<0.05) between both groups. *p < 0.05.
measurements of the first day of life (DOL) were considered
those related to GA and were compared to those at a similar
PMA to study the influence of extrauterine life on the evolution
of these velocities. Considering the first DOL as the transversal
study for each week of gestation, the longitudinal study was
performed excluding this first DOL TnEchos and related to
the corrected age (PMA). We performed linear regression to
determine the associations of all the studied parameters with GA
and PMA.
Returning to the whole study sample, we then performed
mixed-effects logistic regression analysis to study the relationship
of the mentioned velocities longitudinally over time with the
later BPD development, adjusting for repeated TnEchos in each
patient. To test which of the waves should be included in
the multivariate model, we first included all of the measured
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parameters, NTproBNP, GA and PMA, and computed all
possible combinations of the independent variables, allowing
nonhierarchical models. Mallow’s Cp, Akaike Information
Criteria (AIC), Schwarz Bayesian Criterion (BIC), R-squared
(R2) and adjusted R2 (R2Adj) were computed for each subset.
Based on these goodness-of-fit parameters, the theoretical
background and parsimony, we selected two models for further
post-estimation analysis and validated them internally (cross-
validation) and externally (shrinkage).
RESULTS
Study Population
During the recruitment period, 120 VLBWIs were admitted to
the NICU. We excluded 9 (7.5%) that died in the first week
of life, 2 (1.6%) were excluded because they had chromosomal
diseases, and one (0.86%) was excluded due to a congenital
heart defect. A total of 101 subjects with a median birth weight
of 1,115 g (580–1,680 g) and a median GA of 29 weeks (25–32
weeks) were included as the final study sample. Fifteen patients
met the diagnostic criteria for BPD, with five cases of moderate
BPD and 10 cases of severe BPD. Four participants died during
admission, one of them with severe BPD. The patients who
developed BPD had lower GAs and birth weights and had severe
retinopathy of prematurity, hyaline membrane disease and PDA
in greater proportion than the non-BPD patients. They also had a
higher CRIB score, need of postnatal steroids and were ventilated
for a longer period (Table 1). A total of 483 echocardiograms
were performed. Missing values ranged from 2.7% (TAPSE and
E’ wave) to 6.42% (S’ wave). A total of 223 blood samples
were analyzed.
Evolution of TAPSE and TDI in the “Healthy
VLBWI” Subgroup
In the “healthy VLBWI” subgroup, we included 63 patients: 9
(14.3%) in the 25–27+6 week group, 39 (61.9%) in the 28–30+6
week group and 15 (23.8%) in the 31–32+6 week group. The
median birth weight was 1,220 g (600–1,680). Fifteen patients
needed oxygen at 28 DOL but were given room air at 36 PMA.
The perinatal characteristics of this subgroup are summarized
in Table 2.
TAPSE, E’, A’, and S’ increased, and MPI-TDI decreased with
chronological age. All parameters were lower in the group with
the lowest GA (Figure 2, Table S1). We described the predicted
percentiles according to PMA (Figures 3, 4).
As TAPSE differed according to GA compared to PMA [0.83
(95% CI 0.78–0.88) vs. 0.91 (95% CI 0.88–0.94); p = 0.002], we
predicted TAPSEwith both GA and PMA, obtaining the equation
TAPSE (cm/s) = −0.36–0.03xGA + 0.06xPMA (R2 Adj = 0.54,
p = 0.0001). Similarly, an estimation of the RV velocities and
MPI measured by TDI is described in Table 3. The observed and
predicted values of these are presented in the Table S2.
BPD vs. No-BPD Group
As previously mentioned, TAPSE and TDI-derived velocities
were influenced by GA and PMA; therefore, we included both
GA and PMA in the subsequent analysis.
TABLE 2 | Perinatal variables in the “healthy VLBWI” group.
25–27 + 6 GA
(n = 9)
28–30 + 6 GA
(n = 39)
31–32 GA
(n = 15)
Total
(n = 63)
GA 25.78 ± 0.83 29.03 ± 0.74 31.27 ± 0.59 29.10 ± 1.80
Weight (g) 900
(600–1,300)
1,200
(950–1,570)
1,375
(1,215–1,680)
1,220
(600–1,680)
Sex, male 4 (44.4%) 22 (56.41%) 10 (66.67%) 36 (57.14%)
Apgar 5 7 (4–8) 8 (4–10) 8 (6–10) 8 (4–10)
CRIB 2 (1–7) 1 (0–6) 0 (0–1) 1 (0–7)
Chorioamnionitis 1 (11%) 6 (15%) 3 (20%) 10 (16%)
Prenatal steroids
(≥1 dose)
8 (89%) 31 (80%) 14 (93%) 52
Cesarean
section
7 (77%) 30 (76.9%) 12 (80%) 49 (78%)
Early onset
sepsis
0 0 0 0
Late onset
sepsis
3 (33%) 4 (10%) 1 (6.6%) 8 (12.4%)
Hyaline
membrane
disease
6 (66.67%) 27 (69.23%) 3 (20%) 36 (57.14%)
Mechanical
ventilation
8 (88.89%) 26 (66.67%) 3 (20%) 37 (58.73%)
Days of
mechanical
ventilation
14.33 ± 13.14 5.79 ± 7.87 0.87 ± 1.81 5.84 ± 8.80
Postnatal
steroids
0 1 (2.56) 0 1 (1.59%)
iNO 1 (11.11%) 2 (5.13%) 0 3 (4.76%)
Mild BPD 5 (55.5%) 10 (25.6%) 0 15 (23.8%)
Severe IVH 1 (11%) 1 (2.5%) 0 2 (3.1%)
White matter
injury
1 (11%) 1 (2.5%) 0 2 (3.1%)
Severe ROP 1 (11%) 0 0 1 (6.2%)
NEC 1 (11%) 0 0 1 (1.5%)
GA, Gestational age (weeks); iNO, inhaled nitric oxide; BPD, bronchopulmonary dysplasia;
Severe IVH, Grade III intraventricular hemorrhage or parenchymal hemorrhagic infarction;
Severe ROP, retinopathy of prematurity ≥ grade 2; NEC, Necrotizing enterocolitis.
We found a negative correlation between the plasma
NTproBNP levels and TAPSE (Spearman’s Rho = −0.36, p =
0.0001), with similar results regarding diastolic velocities derived
of TDI (data not shown).
In the multivariate study, echocardiography together with
NTproBNP levels at 14 days of life demonstrated good
diagnostic accuracy indices (Table 4). The model that included
NTproBNP at 14 DOL, TAPSE, GA and PMA had an area
under curve (AUC) of 0.988 (95% CI 0.97–1), a sensitivity (Se)
of 68.57% and a specificity (Sp) of 97.51%. See Table 5 for
more details regarding the two selected models. Both models
are reliable with a loss of prediction (shrinkage) of 0.15%
estimated for the model that includes TAPSE, NTproBNP
at14 DOL, GA, and PMA, and a shrinkage of 6.54% for
the model including also E’ and A’. Moreover, both models
are consistent as shown by a mean pseudo R2 of 0.68 and
0.75, respectively.
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FIGURE 2 | Right ventricle echocardiographic parameters in the first month of life by gestational age. y-axis: E’, Lateral tricuspid early diastolic velocity by tissue
doppler (cm/s); A’, Lateral tricuspid late diastolic velocity by tissue doppler (cm/s); TAPSE, Tricuspid annular plane systolic excursion (cm). S’, Lateral tricuspid systolic
velocity by tissue doppler (cm/s). GA, Gestational age (weeks); x-axis, days of life.
FIGURE 3 | Percentiles of lateral tricuspid E’ and A’ in VLBWI by PMA. E’, Lateral tricuspid early diastolic velocity by tissue doppler (E’); A’, Lateral tricuspid late
diastolic velocity by tissue doppler; PMA, postmenstrual age (weeks). The longitudinal study was performed excluding this first day of life TnEchos and related to the
corrected age.
DISCUSSION
This study has allowed us to describe normative data for
the TAPSE and TDI velocities in VLBWIs and to show how
myocardial maturation (measured by TnEcho and NTproBNP at
14 DOL) is different in VLBWIs that develop BPD compared to
in those who do not develop BPD. We have shown how both
birth GA and postnatal life impact TAPSE and TDI velocities
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FIGURE 4 | Percentiles of TAPSE and lateral tricuspid S’ in VLBWI by PMA. TAPSE, Tricuspid annular plane systolic excursion; (S’), Lateral tricuspid systolic velocity
by tissue doppler; PMA, postmenstrual age (weeks). The longitudinal study was performed excluding this first day of life TnEchos and related to the corrected age.
TABLE 3 | Linear regression equations of the right ventricle TnEcho parameters
and TAPSE by gestational age and postmenstrual age.
Predicted TAPSE = −0.359 −0.030 GA + 0.065 PMA
Predicted E’ = −1.055 −0.158 GA + 0.375 PMA
Predicted A’ = 3.110 −0.228 GA + 0.434 PMA
Predicted S’ = 2.446 −0.1921 GA + 0.307 PMA
TAPSE, tricuspid annular plane systolic excursion; GA, Gestational age (weeks); PMA,
postmenstrual age (weeks); E’, early diastolic velocity; A’, late diastolic velocity; S’,
systolic velocity.
TABLE 4 | Goodness of fit parameters of different BPD predictive models.
Included variables* AUC Se Sp AIC BIC
proBNP14 0.976 60.0 99.03 72.3 79.1
proBNP14 + TAPSE 0.988 68.57 97.51 51.1 68.1
proBNP14 + E’ 0.984 75.0 97.04 51 68
proBNP14 + A’ 0.99 80.56 97.04 49.3 66.3
proBNP14 + TAPSE + E’ 0.99 81.82 97.98 50.3 70.7
proBNP14 + TAPSE + A’ 0.99 84.85 98.48 50.2 70.6
proBNP14 +TAPSE + E’+ A’ 0.99 90.91 98.99 44.1 67.9
proBNP14, logarithmic of NTproBNP at 14 days of life; TAPSE, tricuspid annular plane
systolic excursion; E’, early diastolic velocity; A’, late diastolic velocity; AUC, area under
the curve; Se, sensibility; Sp, specificity; AIC, Akaike information criterion; BIC, Bayesian
information criterion.
*Gestational age and postmenstrual age had been included in the predictive models.
and are important factors to consider when performing TnEcho
in VLBWIs.
The myocardium of the VLBWI has different diastolic
properties than that of the term newborn, with fewer contractile
fibers, which is reflected in deficient passive ventricular filling
and a more important contribution of atrial contraction (28).
This results in a higher A’ wave than E’ wave, similar to what
is found during fetal life (29). In addition, TAPSE and RV TDI
velocities were lower in VLBWIs with lower GA, according to
what was previously reported (22, 30). Ourmeasures were similar
to those described by Murase et al. (31) although a complete
comparison of our data with theirs is not possible since they
don’t report numeric data. Also partially similar but inferior to
those described by Ciccone et al. (32), they included preterm
infants of greater gestational age. Moreover, we have also found,
in accordance with the previous literature, a decrease in RV
MPI-TDI over time (19).
Interestingly, as mentioned before, both GA and
chronological age influence TnEcho parameters in VLBWIs.
In children, TDI increases mostly related to age but also to
body surface and heart rate (33). Saleemi et al. (10) reported an
increase in left ventricle TDI measures during the first month
of life in preterm infants <32 weeks of GA. Murase et al. (19)
evaluated the evolution of TDI measures in the first week of
life in VLBWIs. Our study was conducted over a longer study
period and on a higher number of TnECHO cases, with our
patients followed weekly until 36 weeks of PMA. Di Maria et al.
(6) found similar results when comparing TnEcho at 7 DOL
and at 36 weeks of PMA, they observed how GA influences the
results at 7 DOL but not at 36 weeks of PMA. TDI measures in
VLBWIs at the term-corrected age seem to be higher than those
in term newborns at 48 h of life (21). Nevertheless, they found
similar left ventricle function to that of term newborns after the
transitional period (34). Eriksen et al. (35) described differences
in late preterm TDI measures from the transitional period to the
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TABLE 5 | Parameters of the selected BPD predictive models.
Coefficient (CI 95%) p Coefficient (CI 95%) p
TAPSE −5.74 (−10.95 to −0.52) 0.031 −6.68 (−13.14 to −0.23) 0.042
proBNP14 7.26 (3.74–10.79) 0.0001 10.82 (5.05–16.58) 0.0001
GA −1.26 (−1.95 to −0.58) 0.0001 −1.60 (−2.49 to −0.71) 0.0001
PMA 0.38 (0.01–0.75) 0.045 0.31 (−0.12 to −0.75) 0.16
E’ 0.76 (−0.08 to −1.61) 0.075
A’ −0.64 (−1.20 to −0.087) 0.023
Multilevel mixed-effects logistic regression: Log Likelihood = −12.12 Wald
Chi2 (4) = 223.41; p = 0.001; Covar (cc) = 1.71e−24
Multilevel mixed-effects logistic regression: Log Likelihood = −8.67 Wald
Chi2 (6) = 217.15; p = 0.001; Covar (cc)= 3.89e−25
External validation: Shrinkage = 0.15%
Internal validation: Cross-validation: mean pseudo R2 = 0.68
External validation: Shrinkage = 6.54%
Internal validation: Cross-validation: mean pseudo R2 = 0.75
TAPSE, tricuspid annular plane systolic excursion; proBNP14, logarithmic of NTproBNP at 14 days of life; GA, gestational age; PMA, Postmenstrual age; E’, early diastolic velocity;
A’, late diastolic velocity; Covar, covariance.
term-corrected age. Interestingly, normative TDI values in term
newborns and in VLBWIs have been based on studies performed
during the transitional period (26). Not only the chronology of
the assessments make a difference in the compared studies but
it is also important to remark that we excluded those preterm
infants who were IUGR or had HSPDA or BPD when estimating
the normative values while the referred studies use different
inclusion criteria (19, 21, 31). This heterogenicity makes the
values of TnEcho parameters not easy to compare.
There are only a few studies that explore TAPSE in VLBWIs.
There is normative data on normal values of TAPSE in healthy
babies and newborns adjusted for age and body surface area
(7, 36), but data in VLBWIs are lacking. We found similar results
to those reported by Koestenberger et al. (22), who published
TAPSE reference values in VLBWIs by GA in the first 48 h of
life. We have demonstrated how TAPSE values are influenced
by GA and chronological age, and we report our results taking
both into account, not only for TAPSE but also for the MPI-TDI
and RV TDI velocities. We have provided easy-to-use percentile
tables and figures that we think could be helpful when performing
TnEcho in the NICU.
Myocardial function maturation in VLWBIs that develop
BPD seems to be delayed. A previous study from our group
showed how NTproBNP levels at 14 days of life were increased
in those who developed BPD with an optimal cut-off value of
2,264 pg/ml (AUC 0.93; Se 100%; and Sp 86%) (15). Adding
biochemical and echocardiographic markers as soon as 14 DOL
could help identify VLBWIs at a higher risk of developing BPD.
A delay in the MPI decrease measured by a power Doppler has
been reported (4, 37). TAPSE values have been related to early
pulmonary hypertension in VLBWIs (38), but the association
with the later development of BPD has not been previously
explored. When combining NTproBNP levels and TnEcho in
the assessment of VLBWI cardiac function, we found that RV
echocardiographic parameters, GA and PMA, when added to
NTproBNP levels measured at 14 DOL, reach high diagnostic
accuracy indices. The correlation of NTproBNP plasma levels
with TDI has been previously explored in adults, children and,
recently, in VLBWIs with and without PDA (39), showing a
negative correlation between the NTproBNP plasma levels. Our
study has similar results and show how TAPSE and NTproBNP
plasma levels are also associated. In adults, the natriuretic
peptide combined with TDI is used in heart failure evaluations
and when considering dyspnea in a differential diagnosis (40).
In children, the combined biochemical plus echocardiographic
cardiac evaluation could be useful to predict anthracycline-
induced cardiotoxicity (41). In infants aged 6–12 months with
BPD, BNP, and echocardiography have been explored, with no
significant differences (42). Behere et al. have observed that
the increase in BNP and the dilatation of right cavities can
predict the risk of pulmonary hypertension in infants with
BPD; the authors did not observe consistent results with TAPSE
or TDI (43). To our knowledge, this is the first study to
evaluate NTproBNP levels, TAPSE values and RV TDI velocities
in VLBWIs related to the development of BPD. Using both
biochemical and echocardiographic biomarkers in the clinical
settings could be suggested for the identification of VLBWI
with a higher risk of developing BPD. This approach might
help develop new therapeutic/prophylactic strategies in this high
risk population. NTproBNP levels are easy to obtain from a
routine blood sample and are available in a short period of
time and, on the other hand, TnEcho could be performed in
most NICUs, it is safe (44) and reproducible (27). This makes
both techniques widely available and ready to use in routine
clinical practice.
We have explored different predictive models with very close
diagnostic accuracy indices. We suggest including TAPSE since
it is an easy measurement in TnEcho and has good interobserver
and intraobserver reproducibility and reliability (27). Acquiring
TAPSE is easy and fast and can be measured in non-collaborating
patients and even with suboptimal images, making it perfect for
use in VLBWIs. In addition, TAPSE is measured by M-mode, a
conventional ultrasound mode that can be available with no need
for expensive equipment. Amodified TAPSEmeasured, subcostal
TAPSE (S-TAPSE), has been suggested as an useful alternative in
patients with an inadequately visualized four chambers view and
a good correlation with TAPSE has been described in children
and neonates (45).
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Our study has several limitations that need to be addressed.
While this study has a good sample size compared to those
of other studies, a larger sample size, including patients
born before 25 weeks of GA, would strengthen our results.
Nevertheless, the obtained models have proven to have good
internal and external validity, thus could be considered
reliable and reproducible. In the BPD group, the existence
of pulmonary hypertension has not been evaluated, and this
factor could influence the results. To define normative values
of echocardiographic parameters, a subpopulation of VLBWIs
were selected, excluding those with BPD, with hemodynamically
significant PDA or that were small of gestation age. Nevertheless,
other exclusion criteria could be suggested, such as ventilatory
support. A detailed description of the ventilatory parameters
that each patient had while performing the TnEcho is lacking
in our study but TnEcho was always performed on good
respiratory condition with no major events happening as
previously reported (27). However, ventilatory support has
not been found to be correlated with TAPSE (46). As stated
before we would only perform the echocardiographic exams
if the VLBWIs were stable, therefore none of them had
hypotension or need for inotropic supports during a TnEcho.
Thus, our results might not be extrapolated to VLBWIs with
hemodynamic instability.
Our findings suggest that the myocardial function maturation
of VLBWIs depends both on preterm birth itself and on early
extrauterine life exposure. In considering GA and PMA when
performing TnEcho in the VLBWI, we suggest that TnEcho
paired with NTproBNP could be useful for cardiac assessment
in this population and could help identify which of them are
at a higher risk of BPD and would potentially benefit from
preventive strategies.
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